data_1hrl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hrl _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.291 0.567 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.569 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -114.8 -176.74 2.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -0.901 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.79 50.83 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 109.327 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.64 -32.52 7.31 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.12 -140.36 15.28 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 4.3 t -79.99 -23.19 41.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 108.953 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.68 -156.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.351 0.596 . . . . 0.0 109.697 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' ALA . 20.7 m -42.58 115.13 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.677 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 134.09 -35.48 2.23 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' OH ' ' CE1' ' A' ' 2' ' ' PHE . 4.1 m-85 -116.92 152.86 33.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.244 -1.15 . . . . 0.0 109.827 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 43.5 mt -95.2 167.33 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 12' ' ' ARG . 1.5 ptp180 -86.71 114.95 23.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.039 -1.038 . . . . 0.0 110.043 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.526 HG23 ' CA ' ' A' ' 18' ' ' CYS . 3.6 p -89.44 135.32 33.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.062 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.11 -0.64 3.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.751 -0.593 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -90.88 16.51 9.27 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.33 50.35 21.93 Favored Glycine 0 N--CA 1.475 1.254 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.0 -157.8 0.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 0.0 109.765 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.526 ' CA ' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -140.82 130.51 24.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.408 -0.808 . . . . 0.0 109.359 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.53 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -97.52 176.77 1.9 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 108.87 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.0 Cg_endo -80.04 140.19 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.197 1.932 . . . . 0.0 109.913 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 21' ' ' THR . 94.1 m -85.04 30.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.098 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' THR . 3.8 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.693 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -129.49 -166.24 1.63 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 44.48 70.29 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.01 15.13 78.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.48 -127.05 33.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 14.9 t -83.97 -17.89 39.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.7 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.314 0.578 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 7' ' ' ALA . 16.8 m -42.55 119.77 1.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.986 -1.072 . . . . 0.0 110.103 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.22 -37.86 2.54 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.583 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 3.1 m-85 -114.39 160.79 18.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -1.123 . . . . 0.0 109.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 1.7 tp -114.84 172.02 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.405 ' C ' HG23 ' A' ' 13' ' ' THR . 0.3 OUTLIER -83.46 150.89 25.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.721 -1.237 . . . . 0.0 110.527 -179.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.468 ' HB ' ' OD1' ' A' ' 15' ' ' ASP . 73.0 p -138.06 135.12 35.53 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 3.01 0.57 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 112.093 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p-10 -91.77 16.29 11.08 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.825 -1.172 . . . . 0.0 107.869 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.06 38.42 55.32 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG2' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -160.15 -157.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -1.073 . . . . 0.0 109.241 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 11' ' ' LEU . 90.1 m -138.8 151.75 47.31 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 16.7 mtpt -103.64 166.27 12.03 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.99 132.88 9.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.404 2.069 . . . . 0.0 110.352 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' PHE . 94.7 m -86.47 57.48 4.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.067 -1.021 . . . . 0.0 109.55 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.504 ' HB3' ' N ' ' A' ' 6' ' ' CYS . 8.7 m-20 . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.281 0.562 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -88.09 -173.53 4.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.638 ' CB ' ' CE1' ' A' ' 10' ' ' TYR . . . 63.58 40.18 8.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.527 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.31 -28.21 9.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . 139.85 -174.18 22.51 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 6.3 t -84.05 -17.66 39.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -1.109 . . . . 0.0 109.379 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.72 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.222 0.534 . . . . 0.0 109.74 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 8' ' ' THR . 7.4 t -40.0 120.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.077 -1.014 . . . . 0.0 110.231 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.29 -42.02 1.63 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.638 ' CE1' ' CB ' ' A' ' 3' ' ' ALA . 2.2 m-85 -111.9 152.17 28.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -1.166 . . . . 0.0 109.954 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.53 128.56 54.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 8.8 ttp85 -45.04 151.04 0.34 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.251 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.471 ' OG1' ' OD1' ' A' ' 15' ' ' ASP . 7.6 p -125.01 141.61 52.02 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 -1.88 1.54 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.654 -0.654 . . . . 0.0 111.577 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.471 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 8.0 p-10 -93.64 21.49 6.33 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 52.77 46.08 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -160.01 -147.41 0.15 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.512 -0.993 . . . . 0.0 109.382 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -157.85 127.73 6.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.712 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -97.07 163.5 19.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.422 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 34.8 Cg_endo -79.17 127.76 7.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.292 1.995 . . . . 0.0 110.591 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' PHE . 54.3 m -89.42 40.45 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 m-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m-80 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -43.66 126.76 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 32.78 61.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.223 0.535 . . . . 0.0 110.544 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.24 49.12 81.24 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.44 ' C ' ' HB3' ' A' ' 1' ' ' ASN . . . -85.51 26.46 5.76 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 5.2 t -79.92 -21.41 43.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.233 . . . . 0.0 108.806 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.4 -148.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.452 0.644 . . . . 0.0 109.924 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 m -46.73 121.23 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.0 -41.9 1.66 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.541 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 4.7 m-85 -106.5 -168.92 1.48 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.442 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.496 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -153.32 105.37 2.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.017 . . . . 0.0 108.613 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.52 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -33.19 108.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.497 0.665 . . . . 0.0 110.824 -178.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.445 HG23 ' CA ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -89.42 153.72 20.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.405 -0.81 . . . . 0.0 109.165 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 1.27 0.57 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.733 -0.604 . . . . 0.0 111.874 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -92.01 18.2 8.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 67.37 36.15 88.66 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -144.6 -141.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.567 -0.961 . . . . 0.0 109.58 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -152.91 139.54 18.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.316 -0.865 . . . . 0.0 109.354 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 18.7 ptmt -112.92 156.77 42.19 Favored Pre-proline 0 C--N 1.306 -1.321 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.03 143.05 25.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.265 1.977 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.01 50.57 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.489 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 6' ' ' CYS . 10.3 p30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.285 0.564 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.92 -158.03 0.64 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.03 48.22 8.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.78 -23.22 29.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.425 ' HA2' ' OD1' ' A' ' 1' ' ' ASN . . . 110.07 -172.16 15.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.558 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 8.2 t -80.18 -20.31 45.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -1.119 . . . . 0.0 109.286 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.16 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.337 0.589 . . . . 0.0 109.792 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.6 m -46.24 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 21' ' ' THR . . . 155.35 -38.18 0.63 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 2.4 m-85 -115.49 152.3 33.23 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.491 -1.005 . . . . 0.0 109.142 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -93.6 114.93 27.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.751 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' LEU . 12.3 ttm180 -38.5 140.52 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.554 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 19' ' ' LYS . 16.6 p -121.48 133.13 55.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.499 -0.75 . . . . 0.0 109.176 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 1.46 2.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.688 . . . . 0.0 111.524 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.479 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 6.1 p-10 -91.47 16.15 10.89 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.31 29.85 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -158.01 -154.06 0.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -1.099 . . . . 0.0 109.669 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.459 ' CA ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.27 132.7 13.77 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.177 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -98.94 -178.97 0.76 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.301 -0.874 . . . . 0.0 109.335 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 19' ' ' LYS . 36.4 Cg_endo -81.44 133.11 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.524 2.15 . . . . 0.0 110.016 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.506 ' CG2' ' O ' ' A' ' 9' ' ' GLY . 14.9 t -85.77 44.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.691 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CD2' ' C ' ' A' ' 21' ' ' THR . 6.8 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.536 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.74 -171.82 3.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 47.26 60.67 3.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.294 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.49 -35.53 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.42 -152.02 20.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.521 ' O ' ' O ' ' A' ' 7' ' ' ALA . 3.3 t -80.19 -20.98 43.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.535 -0.98 . . . . 0.0 109.54 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.67 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.478 ' O ' HG22 ' A' ' 8' ' ' THR . 9.7 t -46.89 129.97 11.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.667 -1.27 . . . . 0.0 109.206 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 116.03 -34.57 4.66 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.549 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 5.7 m-85 -124.39 153.43 41.88 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.287 -1.125 . . . . 0.0 109.429 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' ARG . 1.1 tp -107.95 117.61 34.58 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -37.3 133.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.758 . . . . 0.0 110.5 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 15' ' ' ASP . 43.2 p -107.88 137.67 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 2.2 0.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.615 -0.678 . . . . 0.0 111.852 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 37.3 p30 -96.76 19.08 13.08 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 17' ' ' ARG . . . 71.38 47.19 36.95 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 4.0 mtp180 -157.81 -142.91 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.443 -1.034 . . . . 0.0 109.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -160.03 140.6 11.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.125 -0.984 . . . . 0.0 109.559 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 2.7 mtpt -100.64 171.58 5.35 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.346 -0.846 . . . . 0.0 109.297 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.495 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 36.2 Cg_endo -79.7 147.27 19.43 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.603 2.202 . . . . 0.0 110.169 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.51 ' CG2' ' O ' ' A' ' 21' ' ' THR . 80.0 m -87.47 33.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.037 -1.04 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' C ' ' O ' ' A' ' 21' ' ' THR . 65.3 m-85 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.822 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.428 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 75.6 m-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.322 0.582 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 3' ' ' ALA . 20.8 t80 -131.62 167.91 18.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.216 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.606 ' N ' ' CG ' ' A' ' 2' ' ' PHE . . . 60.55 60.61 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.44 -8.87 60.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . 96.77 -134.76 11.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.494 ' O ' ' O ' ' A' ' 7' ' ' ALA . 36.5 t -81.78 -17.98 45.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -1.09 . . . . 0.0 109.391 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -52.87 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.465 ' O ' ' CG2' ' A' ' 8' ' ' THR . 12.1 t -40.13 115.09 0.5 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.03 -37.01 1.76 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.8 m-85 -106.87 -170.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -138.97 -158.59 0.87 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.017 -1.052 . . . . 0.0 109.66 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -103.52 118.46 36.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.822 -1.174 . . . . 0.0 110.438 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 19' ' ' LYS . 13.7 p -115.0 130.97 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 0.0 108.866 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.34 1.85 1.45 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.622 -0.674 . . . . 0.0 111.232 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -89.15 14.72 10.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.67 44.14 33.33 Favored Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -155.15 -146.88 0.19 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.505 -0.997 . . . . 0.0 109.021 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 55.8 m -144.59 148.7 34.69 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.27 -0.894 . . . . 0.0 108.943 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -97.29 129.29 32.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.544 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD2' ' HG2' ' A' ' 19' ' ' LYS . 33.4 Cg_endo -75.82 126.45 9.45 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.265 1.977 . . . . 0.0 110.41 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.7 t -88.8 52.8 2.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.2 -0.905 . . . . 0.0 109.979 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.404 ' O ' ' O ' ' A' ' 2' ' ' PHE . 5.6 m120 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 1' ' ' ASN . 1.5 m-85 48.04 -171.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.586 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.87 13.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.27 36.29 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.4 178.18 11.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 7' ' ' ALA . 11.1 t -79.89 -22.92 42.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -56.75 -150.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 8' ' ' THR . 12.8 t -42.38 119.1 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.09 . . . . 0.0 109.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.418 ' O ' HG22 ' A' ' 21' ' ' THR . . . 126.31 -34.19 3.28 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 5.1 m-85 -115.02 -178.51 3.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.24 . . . . 0.0 110.045 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 13' ' ' THR . 0.4 OUTLIER -141.15 104.85 4.71 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.467 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 2.2 mtm180 -39.38 114.47 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 110.965 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.495 ' OG1' ' OD1' ' A' ' 15' ' ' ASP . 1.2 p -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.5 6.51 0.2 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.648 -0.657 . . . . 0.0 112.408 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.495 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 46.6 p-10 -88.36 11.69 16.12 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 76.64 32.7 49.72 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 16' ' ' GLY . 4.6 mmt180 -154.41 -142.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -1.042 . . . . 0.0 108.732 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 32.1 m -153.16 152.7 31.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HE3' ' HD2' ' A' ' 20' ' ' PRO . 12.6 mtpt -111.94 169.48 6.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 109.862 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 35.7 Cg_endo -79.07 130.8 9.56 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.612 2.208 . . . . 0.0 110.144 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.431 ' O ' ' CG2' ' A' ' 21' ' ' THR . 14.4 t -92.56 56.09 2.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 10' ' ' TYR . 15.7 m120 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.282 0.563 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.29 -160.03 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.47 8.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.16 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.94 -42.29 1.2 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 1' ' ' ASN . . . 95.05 -162.07 23.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 7' ' ' ALA . 2.7 t -90.62 -26.65 19.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.442 -1.034 . . . . 0.0 108.946 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.27 -161.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.319 0.58 . . . . 0.0 109.849 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 8' ' ' THR . 6.8 t -40.1 115.04 0.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 109.874 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.5 -40.13 1.59 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 1' ' ' ASN . 4.2 m-85 -107.04 -175.6 2.84 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.177 -1.19 . . . . 0.0 109.628 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.498 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -147.69 114.7 6.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -25.97 110.85 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.718 0.77 . . . . 0.0 112.317 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.554 ' CG2' ' HB3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -85.84 149.48 25.21 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 2.16 0.98 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.674 -0.641 . . . . 0.0 111.486 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 59.5 p30 -95.24 18.45 12.35 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.445 ' C ' ' HG2' ' A' ' 17' ' ' ARG . . . 70.05 41.5 70.74 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 10.3 mmt85 -151.53 -139.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.409 -1.054 . . . . 0.0 108.491 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 63.9 m -152.02 141.02 21.17 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 108.891 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 0.0 OUTLIER -103.34 155.79 36.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.487 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -75.43 137.38 20.72 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.308 2.005 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.455 ' O ' ' OXT' ' A' ' 22' ' ' PHE . 54.0 m -86.54 57.62 4.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' OXT' ' O ' ' A' ' 21' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ASN . . . . . 0.459 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 25.9 m-80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.21 0.529 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -103.83 -155.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 109.241 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.88 28.29 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 109.852 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.37 -35.05 3.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 10' ' ' TYR . . . 114.46 178.64 18.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.557 ' HA ' ' CB ' ' A' ' 10' ' ' TYR . 6.8 t -79.99 -27.34 39.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.122 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -60.03 -141.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 m -45.89 132.8 8.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.758 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.38 -39.93 2.71 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.557 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.5 m-85 -104.24 -167.07 1.31 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.205 -1.173 . . . . 0.0 109.856 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -143.62 101.63 3.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 108.753 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -35.85 113.0 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.614 0.721 . . . . 0.0 111.145 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' A' ' 15' ' ' ASP . 23.6 p -104.83 130.06 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.52 4.47 1.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 111.105 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.451 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 23.3 p-10 -79.94 1.81 25.92 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' ARG . . . 96.38 24.54 14.01 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 13.5 mtt180 -159.95 -146.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -1.113 . . . . 0.0 108.938 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -143.42 157.79 44.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 109.6 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' C ' ' CD2' ' A' ' 10' ' ' TYR . 3.6 ttpt -112.97 135.7 21.69 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.3 Cg_endo -74.84 143.68 29.94 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.043 1.829 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -85.21 52.67 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.718 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.557 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 9.0 tp10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.388 0.613 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.507 ' N ' ' HG3' ' A' ' 0' ' ' GLU . 46.3 m-20 -43.28 148.63 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 109.641 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.569 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -114.8 -176.74 2.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -0.901 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.79 50.83 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 109.327 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.64 -32.52 7.31 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.12 -140.36 15.28 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 4.3 t -79.99 -23.19 41.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 108.953 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.68 -156.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.351 0.596 . . . . 0.0 109.697 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' ALA . 20.7 m -42.58 115.13 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.677 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 134.09 -35.48 2.23 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' OH ' ' CE1' ' A' ' 2' ' ' PHE . 4.1 m-85 -116.92 152.86 33.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.244 -1.15 . . . . 0.0 109.827 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 43.5 mt -95.2 167.33 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.455 ' CG ' ' O ' ' A' ' 12' ' ' ARG . 1.5 ptp180 -86.71 114.95 23.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.039 -1.038 . . . . 0.0 110.043 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.526 HG23 ' CA ' ' A' ' 18' ' ' CYS . 3.6 p -89.44 135.32 33.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.062 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.11 -0.64 3.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.751 -0.593 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -90.88 16.51 9.27 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.33 50.35 21.93 Favored Glycine 0 N--CA 1.475 1.254 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.418 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.0 -157.8 0.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 0.0 109.765 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.526 ' CA ' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -140.82 130.51 24.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.408 -0.808 . . . . 0.0 109.359 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.53 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -97.52 176.77 1.9 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 108.87 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.0 Cg_endo -80.04 140.19 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.197 1.932 . . . . 0.0 109.913 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.499 ' O ' ' CG2' ' A' ' 21' ' ' THR . 94.1 m -85.04 30.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.098 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' THR . 3.8 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.693 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 1' ' ' ASN . 16.9 tp10 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.188 0.518 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.431 ' H ' ' HG3' ' A' ' 0' ' ' GLU . 28.1 p-10 -69.93 152.56 44.33 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 109.489 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -129.49 -166.24 1.63 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 44.48 70.29 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.01 15.13 78.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.48 -127.05 33.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 14.9 t -83.97 -17.89 39.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.7 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.314 0.578 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 7' ' ' ALA . 16.8 m -42.55 119.77 1.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.986 -1.072 . . . . 0.0 110.103 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.22 -37.86 2.54 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.583 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 3.1 m-85 -114.39 160.79 18.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -1.123 . . . . 0.0 109.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 1.7 tp -114.84 172.02 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.405 ' C ' HG23 ' A' ' 13' ' ' THR . 0.3 OUTLIER -83.46 150.89 25.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.721 -1.237 . . . . 0.0 110.527 -179.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.468 ' HB ' ' OD1' ' A' ' 15' ' ' ASP . 73.0 p -138.06 135.12 35.53 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 3.01 0.57 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 112.093 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p-10 -91.77 16.29 11.08 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.825 -1.172 . . . . 0.0 107.869 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.06 38.42 55.32 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HG2' ' NH1' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -160.15 -157.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -1.073 . . . . 0.0 109.241 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.504 ' HB3' ' O ' ' A' ' 11' ' ' LEU . 90.1 m -138.8 151.75 47.31 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 16.7 mtpt -103.64 166.27 12.03 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.99 132.88 9.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.404 2.069 . . . . 0.0 110.352 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' PHE . 94.7 m -86.47 57.48 4.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.067 -1.021 . . . . 0.0 109.55 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 11.0 pt-20 . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.504 ' HB3' ' N ' ' A' ' 6' ' ' CYS . 8.7 m-20 -41.39 111.76 0.25 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.324 -0.86 . . . . 0.0 109.874 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -88.09 -173.53 4.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.638 ' CB ' ' CE1' ' A' ' 10' ' ' TYR . . . 63.58 40.18 8.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.527 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.31 -28.21 9.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.463 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . 139.85 -174.18 22.51 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.534 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 6.3 t -84.05 -17.66 39.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -1.109 . . . . 0.0 109.379 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.72 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.222 0.534 . . . . 0.0 109.74 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' A' ' 8' ' ' THR . 7.4 t -40.0 120.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.077 -1.014 . . . . 0.0 110.231 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.29 -42.02 1.63 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.638 ' CE1' ' CB ' ' A' ' 3' ' ' ALA . 2.2 m-85 -111.9 152.17 28.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -1.166 . . . . 0.0 109.954 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.53 128.56 54.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 8.8 ttp85 -45.04 151.04 0.34 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.251 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.471 ' OG1' ' OD1' ' A' ' 15' ' ' ASP . 7.6 p -125.01 141.61 52.02 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 -1.88 1.54 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.654 -0.654 . . . . 0.0 111.577 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.471 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 8.0 p-10 -93.64 21.49 6.33 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 52.77 46.08 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -160.01 -147.41 0.15 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.512 -0.993 . . . . 0.0 109.382 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -157.85 127.73 6.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.712 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.478 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -97.07 163.5 19.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.422 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 34.8 Cg_endo -79.17 127.76 7.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.292 1.995 . . . . 0.0 110.591 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' PHE . 54.3 m -89.42 40.45 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 m-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 12.2 pt-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m-80 -51.22 106.61 0.14 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -0.93 . . . . 0.0 109.055 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -43.66 126.76 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 32.78 61.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.223 0.535 . . . . 0.0 110.544 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.24 49.12 81.24 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.44 ' C ' ' HB3' ' A' ' 1' ' ' ASN . . . -85.51 26.46 5.76 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 5.2 t -79.92 -21.41 43.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.233 . . . . 0.0 108.806 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.4 -148.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.452 0.644 . . . . 0.0 109.924 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 m -46.73 121.23 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.0 -41.9 1.66 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.541 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 4.7 m-85 -106.5 -168.92 1.48 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.442 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.496 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -153.32 105.37 2.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.017 . . . . 0.0 108.613 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.52 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -33.19 108.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.497 0.665 . . . . 0.0 110.824 -178.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.445 HG23 ' CA ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -89.42 153.72 20.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.405 -0.81 . . . . 0.0 109.165 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 1.27 0.57 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.733 -0.604 . . . . 0.0 111.874 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 p30 -92.01 18.2 8.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 67.37 36.15 88.66 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -144.6 -141.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.567 -0.961 . . . . 0.0 109.58 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.52 ' SG ' ' N ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -152.91 139.54 18.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.316 -0.865 . . . . 0.0 109.354 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' LEU . 18.7 ptmt -112.92 156.77 42.19 Favored Pre-proline 0 C--N 1.306 -1.321 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.03 143.05 25.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.265 1.977 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.01 50.57 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.489 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 5.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.507 ' N ' ' HG3' ' A' ' 0' ' ' GLU . 10.3 p30 -37.12 127.95 0.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.686 -0.634 . . . . 0.0 110.083 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.92 -158.03 0.64 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.03 48.22 8.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.78 -23.22 29.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.425 ' HA2' ' OD1' ' A' ' 1' ' ' ASN . . . 110.07 -172.16 15.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.558 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 8.2 t -80.18 -20.31 45.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -1.119 . . . . 0.0 109.286 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.16 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.337 0.589 . . . . 0.0 109.792 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.6 m -46.24 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 21' ' ' THR . . . 155.35 -38.18 0.63 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 19' ' ' LYS . 2.4 m-85 -115.49 152.3 33.23 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.491 -1.005 . . . . 0.0 109.142 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -93.6 114.93 27.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.751 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' LEU . 12.3 ttm180 -38.5 140.52 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.554 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.484 HG22 ' HB3' ' A' ' 19' ' ' LYS . 16.6 p -121.48 133.13 55.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.499 -0.75 . . . . 0.0 109.176 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 1.46 2.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.688 . . . . 0.0 111.524 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.479 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 6.1 p-10 -91.47 16.15 10.89 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.31 29.85 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.438 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -158.01 -154.06 0.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -1.099 . . . . 0.0 109.669 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.459 ' CA ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.27 132.7 13.77 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.177 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -98.94 -178.97 0.76 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.301 -0.874 . . . . 0.0 109.335 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.526 ' CD ' ' CB ' ' A' ' 19' ' ' LYS . 36.4 Cg_endo -81.44 133.11 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.524 2.15 . . . . 0.0 110.016 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.506 ' CG2' ' O ' ' A' ' 9' ' ' GLY . 14.9 t -85.77 44.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.691 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CD2' ' C ' ' A' ' 21' ' ' THR . 6.8 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.536 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 2.2 tp10 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.397 0.618 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.542 ' N ' ' HG3' ' A' ' 0' ' ' GLU . 0.3 OUTLIER -42.25 147.16 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.488 -0.758 . . . . 0.0 109.566 179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.74 -171.82 3.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 47.26 60.67 3.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.294 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.49 -35.53 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.42 -152.02 20.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.521 ' O ' ' O ' ' A' ' 7' ' ' ALA . 3.3 t -80.19 -20.98 43.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.535 -0.98 . . . . 0.0 109.54 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.67 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.478 ' O ' HG22 ' A' ' 8' ' ' THR . 9.7 t -46.89 129.97 11.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.667 -1.27 . . . . 0.0 109.206 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 116.03 -34.57 4.66 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.549 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 5.7 m-85 -124.39 153.43 41.88 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.287 -1.125 . . . . 0.0 109.429 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' ARG . 1.1 tp -107.95 117.61 34.58 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -37.3 133.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.758 . . . . 0.0 110.5 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 15' ' ' ASP . 43.2 p -107.88 137.67 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 2.2 0.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.615 -0.678 . . . . 0.0 111.852 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 37.3 p30 -96.76 19.08 13.08 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.496 ' O ' ' CG ' ' A' ' 17' ' ' ARG . . . 71.38 47.19 36.95 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 4.0 mtp180 -157.81 -142.91 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.443 -1.034 . . . . 0.0 109.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -160.03 140.6 11.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.125 -0.984 . . . . 0.0 109.559 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 2.7 mtpt -100.64 171.58 5.35 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.346 -0.846 . . . . 0.0 109.297 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.495 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 36.2 Cg_endo -79.7 147.27 19.43 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.603 2.202 . . . . 0.0 110.169 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.51 ' O ' ' CG2' ' A' ' 21' ' ' THR . 80.0 m -87.47 33.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.037 -1.04 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' C ' ' O ' ' A' ' 21' ' ' THR . 65.3 m-85 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.822 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.436 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.306 0.574 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.428 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 75.6 m-20 47.61 -168.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.503 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 3' ' ' ALA . 20.8 t80 -131.62 167.91 18.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.216 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.606 ' N ' ' CG ' ' A' ' 2' ' ' PHE . . . 60.55 60.61 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.44 -8.87 60.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 0' ' ' GLU . . . 96.77 -134.76 11.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' O ' ' O ' ' A' ' 7' ' ' ALA . 36.5 t -81.78 -17.98 45.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -1.09 . . . . 0.0 109.391 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -52.87 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.465 ' O ' ' CG2' ' A' ' 8' ' ' THR . 12.1 t -40.13 115.09 0.5 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 140.03 -37.01 1.76 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.8 m-85 -106.87 -170.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -138.97 -158.59 0.87 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.017 -1.052 . . . . 0.0 109.66 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -103.52 118.46 36.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.822 -1.174 . . . . 0.0 110.438 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 19' ' ' LYS . 13.7 p -115.0 130.97 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 0.0 108.866 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.34 1.85 1.45 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.622 -0.674 . . . . 0.0 111.232 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -89.15 14.72 10.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.67 44.14 33.33 Favored Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -155.15 -146.88 0.19 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.505 -0.997 . . . . 0.0 109.021 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 55.8 m -144.59 148.7 34.69 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.27 -0.894 . . . . 0.0 108.943 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -97.29 129.29 32.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.544 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD2' ' HG2' ' A' ' 19' ' ' LYS . 33.4 Cg_endo -75.82 126.45 9.45 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.265 1.977 . . . . 0.0 110.41 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.447 ' O ' ' C ' ' A' ' 22' ' ' PHE . 1.7 t -88.8 52.8 2.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.2 -0.905 . . . . 0.0 109.979 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 1' ' ' ASN . 2.2 pt-20 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 0' ' ' GLU . 5.6 m120 74.29 45.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 1' ' ' ASN . 1.5 m-85 48.04 -171.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.586 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.87 13.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.27 36.29 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.4 178.18 11.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 7' ' ' ALA . 11.1 t -79.89 -22.92 42.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -56.75 -150.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.494 ' CG2' ' O ' ' A' ' 8' ' ' THR . 12.8 t -42.38 119.1 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.09 . . . . 0.0 109.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.418 ' O ' HG22 ' A' ' 21' ' ' THR . . . 126.31 -34.19 3.28 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 5.1 m-85 -115.02 -178.51 3.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.24 . . . . 0.0 110.045 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 13' ' ' THR . 0.4 OUTLIER -141.15 104.85 4.71 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.467 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 2.2 mtm180 -39.38 114.47 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 110.965 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.495 ' OG1' ' OD1' ' A' ' 15' ' ' ASP . 1.2 p -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.5 6.51 0.2 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.648 -0.657 . . . . 0.0 112.408 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.495 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 46.6 p-10 -88.36 11.69 16.12 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 76.64 32.7 49.72 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 16' ' ' GLY . 4.6 mmt180 -154.41 -142.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -1.042 . . . . 0.0 108.732 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 32.1 m -153.16 152.7 31.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HE3' ' HD2' ' A' ' 20' ' ' PRO . 12.6 mtpt -111.94 169.48 6.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 109.862 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 35.7 Cg_endo -79.07 130.8 9.56 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.612 2.208 . . . . 0.0 110.144 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.431 ' O ' ' CG2' ' A' ' 21' ' ' THR . 14.4 t -92.56 56.09 2.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 1' ' ' ASN . 5.7 pt-20 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 10' ' ' TYR . 15.7 m120 56.87 111.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.868 . . . . 0.0 109.675 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.29 -160.03 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.47 8.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.16 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.94 -42.29 1.2 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 1' ' ' ASN . . . 95.05 -162.07 23.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 7' ' ' ALA . 2.7 t -90.62 -26.65 19.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.442 -1.034 . . . . 0.0 108.946 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.27 -161.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.319 0.58 . . . . 0.0 109.849 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 8' ' ' THR . 6.8 t -40.1 115.04 0.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 109.874 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.5 -40.13 1.59 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 1' ' ' ASN . 4.2 m-85 -107.04 -175.6 2.84 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.177 -1.19 . . . . 0.0 109.628 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.498 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -147.69 114.7 6.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -25.97 110.85 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.718 0.77 . . . . 0.0 112.317 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.554 ' CG2' ' HB3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -85.84 149.48 25.21 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 2.16 0.98 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.674 -0.641 . . . . 0.0 111.486 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 59.5 p30 -95.24 18.45 12.35 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.445 ' C ' ' HG2' ' A' ' 17' ' ' ARG . . . 70.05 41.5 70.74 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 10.3 mmt85 -151.53 -139.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.409 -1.054 . . . . 0.0 108.491 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 63.9 m -152.02 141.02 21.17 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 108.891 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.554 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 0.0 OUTLIER -103.34 155.79 36.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.487 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -75.43 137.38 20.72 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.308 2.005 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.455 ' O ' ' OXT' ' A' ' 22' ' ' PHE . 54.0 m -86.54 57.62 4.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' OXT' ' O ' ' A' ' 21' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 1' ' ' ASN . 9.0 tp10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 0' ' ' GLU . 25.9 m-80 60.72 127.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.639 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -103.83 -155.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 109.241 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.88 28.29 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 109.852 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.37 -35.05 3.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 10' ' ' TYR . . . 114.46 178.64 18.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.557 ' HA ' ' CB ' ' A' ' 10' ' ' TYR . 6.8 t -79.99 -27.34 39.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.122 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -60.03 -141.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 m -45.89 132.8 8.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.758 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.38 -39.93 2.71 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.557 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.5 m-85 -104.24 -167.07 1.31 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.205 -1.173 . . . . 0.0 109.856 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -143.62 101.63 3.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 108.753 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.487 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -35.85 113.0 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.614 0.721 . . . . 0.0 111.145 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.451 ' OG1' ' OD1' ' A' ' 15' ' ' ASP . 23.6 p -104.83 130.06 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.52 4.47 1.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 111.105 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 23.3 p-10 -79.94 1.81 25.92 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' ARG . . . 96.38 24.54 14.01 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 13.5 mtt180 -159.95 -146.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -1.113 . . . . 0.0 108.938 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -143.42 157.79 44.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 109.6 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' C ' ' CD2' ' A' ' 10' ' ' TYR . 3.6 ttpt -112.97 135.7 21.69 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.3 Cg_endo -74.84 143.68 29.94 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.043 1.829 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -85.21 52.67 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.718 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.557 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.291 0.567 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.569 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -114.8 -176.74 2.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -0.901 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 2' ' ' PHE . . . 60.79 50.83 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 109.327 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.64 -32.52 7.31 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.12 -140.36 15.28 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 4.3 t -79.99 -23.19 41.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 108.953 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.68 -156.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.351 0.596 . . . . 0.0 109.697 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' ALA . 20.7 m -42.58 115.13 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.677 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 134.09 -35.48 2.23 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' OH ' ' CE1' ' A' ' 2' ' ' PHE . 4.1 m-85 -116.92 152.86 33.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.244 -1.15 . . . . 0.0 109.827 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 43.5 mt -95.2 167.33 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 12' ' ' ARG . 1.5 ptp180 -86.71 114.95 23.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.039 -1.038 . . . . 0.0 110.043 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 19' ' ' LYS . 3.6 p -89.44 135.32 33.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.062 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.11 -0.64 3.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.751 -0.593 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.476 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -90.88 16.51 9.27 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.33 50.35 21.93 Favored Glycine 0 N--CA 1.475 1.254 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.0 -157.8 0.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 0.0 109.765 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HA ' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -140.82 130.51 24.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.408 -0.808 . . . . 0.0 109.359 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -97.52 176.77 1.9 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 108.87 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.0 Cg_endo -80.04 140.19 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.197 1.932 . . . . 0.0 109.913 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 21' ' ' THR . 94.1 m -85.04 30.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.098 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' THR . 3.8 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.693 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -129.49 -166.24 1.63 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 44.48 70.29 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.01 15.13 78.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.48 -127.05 33.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 14.9 t -83.97 -17.89 39.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.7 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.314 0.578 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 7' ' ' ALA . 16.8 m -42.55 119.77 1.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.986 -1.072 . . . . 0.0 110.103 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.22 -37.86 2.54 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.583 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 3.1 m-85 -114.39 160.79 18.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -1.123 . . . . 0.0 109.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 1.7 tp -114.84 172.02 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.46 150.89 25.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.721 -1.237 . . . . 0.0 110.527 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 18' ' ' CYS . 73.0 p -138.06 135.12 35.53 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 3.01 0.57 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 112.093 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p-10 -91.77 16.29 11.08 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.825 -1.172 . . . . 0.0 107.869 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.06 38.42 55.32 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.15 -157.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -1.073 . . . . 0.0 109.241 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 90.1 m -138.8 151.75 47.31 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 16.7 mtpt -103.64 166.27 12.03 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.99 132.88 9.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.404 2.069 . . . . 0.0 110.352 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.591 ' O ' HG22 ' A' ' 21' ' ' THR . 94.7 m -86.47 57.48 4.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.067 -1.021 . . . . 0.0 109.55 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.525 ' HB3' ' N ' ' A' ' 6' ' ' CYS . 8.7 m-20 . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.281 0.562 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 4.5 m-85 -88.09 -173.53 4.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.745 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . . . 63.58 40.18 8.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.527 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.31 -28.21 9.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . 139.85 -174.18 22.51 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 6.3 t -84.05 -17.66 39.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -1.109 . . . . 0.0 109.379 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.72 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.222 0.534 . . . . 0.0 109.74 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 8' ' ' THR . 7.4 t -40.0 120.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.077 -1.014 . . . . 0.0 110.231 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.29 -42.02 1.63 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.745 ' CE1' ' HB3' ' A' ' 3' ' ' ALA . 2.2 m-85 -111.9 152.17 28.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -1.166 . . . . 0.0 109.954 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.53 128.56 54.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 8.8 ttp85 -45.04 151.04 0.34 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.251 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.414 ' OG1' ' C ' ' A' ' 17' ' ' ARG . 7.6 p -125.01 141.61 52.02 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 -1.88 1.54 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.654 -0.654 . . . . 0.0 111.577 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 8.0 p-10 -93.64 21.49 6.33 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 52.77 46.08 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -160.01 -147.41 0.15 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.512 -0.993 . . . . 0.0 109.382 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -157.85 127.73 6.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.712 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -97.07 163.5 19.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.422 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.538 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 34.8 Cg_endo -79.17 127.76 7.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.292 1.995 . . . . 0.0 110.591 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 21' ' ' THR . 54.3 m -89.42 40.45 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 m-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m-80 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -43.66 126.76 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 32.78 61.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.223 0.535 . . . . 0.0 110.544 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.24 49.12 81.24 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 1' ' ' ASN . . . -85.51 26.46 5.76 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 5.2 t -79.92 -21.41 43.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.233 . . . . 0.0 108.806 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.4 -148.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.452 0.644 . . . . 0.0 109.924 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 m -46.73 121.23 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.0 -41.9 1.66 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 4.7 m-85 -106.5 -168.92 1.48 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.442 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.496 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -153.32 105.37 2.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.017 . . . . 0.0 108.613 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.52 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -33.19 108.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.497 0.665 . . . . 0.0 110.824 -178.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.547 HG22 ' CA ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -89.42 153.72 20.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.405 -0.81 . . . . 0.0 109.165 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 1.27 0.57 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.733 -0.604 . . . . 0.0 111.874 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.5 ' OD1' HG23 ' A' ' 13' ' ' THR . 25.3 p30 -92.01 18.2 8.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 67.37 36.15 88.66 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -144.6 -141.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.567 -0.961 . . . . 0.0 109.58 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.547 ' CA ' HG22 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.91 139.54 18.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.316 -0.865 . . . . 0.0 109.354 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 18.7 ptmt -112.92 156.77 42.19 Favored Pre-proline 0 C--N 1.306 -1.321 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.03 143.05 25.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.265 1.977 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.01 50.57 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.489 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 6' ' ' CYS . 10.3 p30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.285 0.564 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.92 -158.03 0.64 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.68 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . . . 60.03 48.22 8.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.78 -23.22 29.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.438 ' HA2' ' OD1' ' A' ' 1' ' ' ASN . . . 110.07 -172.16 15.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 8.2 t -80.18 -20.31 45.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -1.119 . . . . 0.0 109.286 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.16 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.337 0.589 . . . . 0.0 109.792 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.6 m -46.24 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.747 ' O ' HG22 ' A' ' 21' ' ' THR . . . 155.35 -38.18 0.63 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.68 ' CE1' ' HB3' ' A' ' 3' ' ' ALA . 2.4 m-85 -115.49 152.3 33.23 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.491 -1.005 . . . . 0.0 109.142 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -93.6 114.93 27.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.751 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' LEU . 12.3 ttm180 -38.5 140.52 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.554 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.769 HG23 ' HA ' ' A' ' 18' ' ' CYS . 16.6 p -121.48 133.13 55.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.499 -0.75 . . . . 0.0 109.176 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 1.46 2.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.688 . . . . 0.0 111.524 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 6.1 p-10 -91.47 16.15 10.89 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.31 29.85 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -158.01 -154.06 0.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -1.099 . . . . 0.0 109.669 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.769 ' HA ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.27 132.7 13.77 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.177 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -98.94 -178.97 0.76 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.301 -0.874 . . . . 0.0 109.335 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.4 Cg_endo -81.44 133.11 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.524 2.15 . . . . 0.0 110.016 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 9' ' ' GLY . 14.9 t -85.77 44.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.691 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CD2' ' C ' ' A' ' 21' ' ' THR . 6.8 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.536 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.74 -171.82 3.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 47.26 60.67 3.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.294 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.49 -35.53 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.42 -152.02 20.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 3.3 t -80.19 -20.98 43.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.535 -0.98 . . . . 0.0 109.54 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.67 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 8' ' ' THR . 9.7 t -46.89 129.97 11.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.667 -1.27 . . . . 0.0 109.206 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 116.03 -34.57 4.66 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.549 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 5.7 m-85 -124.39 153.43 41.88 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.287 -1.125 . . . . 0.0 109.429 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' ARG . 1.1 tp -107.95 117.61 34.58 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.481 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -37.3 133.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.758 . . . . 0.0 110.5 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 19' ' ' LYS . 43.2 p -107.88 137.67 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 2.2 0.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.615 -0.678 . . . . 0.0 111.852 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -96.76 19.08 13.08 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 71.38 47.19 36.95 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 4.0 mtp180 -157.81 -142.91 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.443 -1.034 . . . . 0.0 109.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -160.03 140.6 11.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.125 -0.984 . . . . 0.0 109.559 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 2.7 mtpt -100.64 171.58 5.35 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.346 -0.846 . . . . 0.0 109.297 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.513 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 36.2 Cg_endo -79.7 147.27 19.43 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.603 2.202 . . . . 0.0 110.169 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 21' ' ' THR . 80.0 m -87.47 33.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.037 -1.04 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' C ' ' O ' ' A' ' 21' ' ' THR . 65.3 m-85 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.822 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.455 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 4.3 m120 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.322 0.582 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 3' ' ' ALA . 20.8 t80 -131.62 167.91 18.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.216 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.606 ' N ' ' CG ' ' A' ' 2' ' ' PHE . . . 60.55 60.61 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.44 -8.87 60.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . 96.77 -134.76 11.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.494 ' O ' ' O ' ' A' ' 7' ' ' ALA . 36.5 t -81.78 -17.98 45.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -1.09 . . . . 0.0 109.391 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -52.87 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 8' ' ' THR . 12.1 t -40.13 115.09 0.5 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 21' ' ' THR . . . 140.03 -37.01 1.76 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.8 m-85 -106.87 -170.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.687 HD23 ' H ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -138.97 -158.59 0.87 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.017 -1.052 . . . . 0.0 109.66 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.687 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.4 ttm-85 -103.52 118.46 36.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.822 -1.174 . . . . 0.0 110.438 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.453 ' OG1' ' C ' ' A' ' 17' ' ' ARG . 13.7 p -115.0 130.97 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 0.0 108.866 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.34 1.85 1.45 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.622 -0.674 . . . . 0.0 111.232 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -89.15 14.72 10.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.67 44.14 33.33 Favored Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -155.15 -146.88 0.19 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.505 -0.997 . . . . 0.0 109.021 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 55.8 m -144.59 148.7 34.69 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.27 -0.894 . . . . 0.0 108.943 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -97.29 129.29 32.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.544 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 19' ' ' LYS . 33.4 Cg_endo -75.82 126.45 9.45 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.265 1.977 . . . . 0.0 110.41 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 9' ' ' GLY . 1.7 t -88.8 52.8 2.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.2 -0.905 . . . . 0.0 109.979 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 5.6 m120 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 1' ' ' ASN . 1.5 m-85 48.04 -171.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.586 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.87 13.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.27 36.29 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.4 178.18 11.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 11.1 t -79.89 -22.92 42.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -56.75 -150.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 8' ' ' THR . 12.8 t -42.38 119.1 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.09 . . . . 0.0 109.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 21' ' ' THR . . . 126.31 -34.19 3.28 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' HD22 ' A' ' 11' ' ' LEU . 5.1 m-85 -115.02 -178.51 3.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.24 . . . . 0.0 110.045 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -141.15 104.85 4.71 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.476 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 2.2 mtm180 -39.38 114.47 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 110.965 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 18' ' ' CYS . 1.2 p -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.5 6.51 0.2 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.648 -0.657 . . . . 0.0 112.408 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.495 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 46.6 p-10 -88.36 11.69 16.12 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 76.64 32.7 49.72 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 16' ' ' GLY . 4.6 mmt180 -154.41 -142.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -1.042 . . . . 0.0 108.732 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HA ' HG23 ' A' ' 13' ' ' THR . 32.1 m -153.16 152.7 31.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HG3' HG21 ' A' ' 13' ' ' THR . 12.6 mtpt -111.94 169.48 6.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 109.862 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 35.7 Cg_endo -79.07 130.8 9.56 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.612 2.208 . . . . 0.0 110.144 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 9' ' ' GLY . 14.4 t -92.56 56.09 2.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 10' ' ' TYR . 15.7 m120 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.282 0.563 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.29 -160.03 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.47 8.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.16 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.94 -42.29 1.2 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 1' ' ' ASN . . . 95.05 -162.07 23.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 7' ' ' ALA . 2.7 t -90.62 -26.65 19.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.442 -1.034 . . . . 0.0 108.946 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.27 -161.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.319 0.58 . . . . 0.0 109.849 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.671 ' O ' HG23 ' A' ' 8' ' ' THR . 6.8 t -40.1 115.04 0.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 109.874 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.5 -40.13 1.59 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' A' ' 1' ' ' ASN . 4.2 m-85 -107.04 -175.6 2.84 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.177 -1.19 . . . . 0.0 109.628 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -147.69 114.7 6.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -25.97 110.85 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.718 0.77 . . . . 0.0 112.317 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -85.84 149.48 25.21 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 2.16 0.98 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.674 -0.641 . . . . 0.0 111.486 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 59.5 p30 -95.24 18.45 12.35 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' C ' ' HG2' ' A' ' 17' ' ' ARG . . . 70.05 41.5 70.74 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 10.3 mmt85 -151.53 -139.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.409 -1.054 . . . . 0.0 108.491 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 63.9 m -152.02 141.02 21.17 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 108.891 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.72 ' HB3' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -103.34 155.79 36.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -75.43 137.38 20.72 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.308 2.005 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 21' ' ' THR . 54.0 m -86.54 57.62 4.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' OXT' ' O ' ' A' ' 21' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ASN . . . . . 0.461 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 25.9 m-80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.21 0.529 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -103.83 -155.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 109.241 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.88 28.29 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 109.852 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.37 -35.05 3.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 10' ' ' TYR . . . 114.46 178.64 18.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.571 ' HA ' ' CB ' ' A' ' 10' ' ' TYR . 6.8 t -79.99 -27.34 39.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.122 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -60.03 -141.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 m -45.89 132.8 8.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.758 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.38 -39.93 2.71 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.571 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.5 m-85 -104.24 -167.07 1.31 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.205 -1.173 . . . . 0.0 109.856 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -143.62 101.63 3.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 108.753 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -35.85 113.0 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.614 0.721 . . . . 0.0 111.145 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 11' ' ' LEU . 23.6 p -104.83 130.06 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.52 4.47 1.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 111.105 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.94 1.81 25.92 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' ARG . . . 96.38 24.54 14.01 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 13.5 mtt180 -159.95 -146.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -1.113 . . . . 0.0 108.938 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -143.42 157.79 44.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 109.6 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' C ' ' CD2' ' A' ' 10' ' ' TYR . 3.6 ttpt -112.97 135.7 21.69 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.3 Cg_endo -74.84 143.68 29.94 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.043 1.829 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -85.21 52.67 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.718 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.557 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 9.0 tp10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.388 0.613 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 0' ' ' GLU . 9.9 m120 -43.28 148.63 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 109.641 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.569 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -114.8 -176.74 2.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -0.901 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 2' ' ' PHE . . . 60.79 50.83 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 109.327 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.64 -32.52 7.31 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.12 -140.36 15.28 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 4.3 t -79.99 -23.19 41.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 108.953 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.68 -156.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.351 0.596 . . . . 0.0 109.697 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' ALA . 20.7 m -42.58 115.13 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.677 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 134.09 -35.48 2.23 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' OH ' ' CE1' ' A' ' 2' ' ' PHE . 4.1 m-85 -116.92 152.86 33.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.244 -1.15 . . . . 0.0 109.827 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 43.5 mt -95.2 167.33 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 12' ' ' ARG . 1.5 ptp180 -86.71 114.95 23.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.039 -1.038 . . . . 0.0 110.043 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 19' ' ' LYS . 3.6 p -89.44 135.32 33.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.062 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.11 -0.64 3.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.751 -0.593 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.476 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -90.88 16.51 9.27 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.33 50.35 21.93 Favored Glycine 0 N--CA 1.475 1.254 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.0 -157.8 0.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 0.0 109.765 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HA ' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -140.82 130.51 24.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.408 -0.808 . . . . 0.0 109.359 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -97.52 176.77 1.9 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 108.87 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.0 Cg_endo -80.04 140.19 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.197 1.932 . . . . 0.0 109.913 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 21' ' ' THR . 94.1 m -85.04 30.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.098 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' THR . 3.8 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.693 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 1' ' ' ASN . 16.9 tp10 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.188 0.518 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.433 ' H ' ' HG3' ' A' ' 0' ' ' GLU . 28.1 p-10 -69.93 152.56 44.33 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 109.489 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -129.49 -166.24 1.63 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 44.48 70.29 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.01 15.13 78.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.48 -127.05 33.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 14.9 t -83.97 -17.89 39.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.7 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.314 0.578 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 7' ' ' ALA . 16.8 m -42.55 119.77 1.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.986 -1.072 . . . . 0.0 110.103 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.22 -37.86 2.54 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.583 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 3.1 m-85 -114.39 160.79 18.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -1.123 . . . . 0.0 109.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 1.7 tp -114.84 172.02 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.46 150.89 25.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.721 -1.237 . . . . 0.0 110.527 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 18' ' ' CYS . 73.0 p -138.06 135.12 35.53 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 3.01 0.57 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 112.093 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p-10 -91.77 16.29 11.08 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.825 -1.172 . . . . 0.0 107.869 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.06 38.42 55.32 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.15 -157.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -1.073 . . . . 0.0 109.241 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 90.1 m -138.8 151.75 47.31 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 16.7 mtpt -103.64 166.27 12.03 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.99 132.88 9.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.404 2.069 . . . . 0.0 110.352 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 21' ' ' THR . 94.7 m -86.47 57.48 4.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.067 -1.021 . . . . 0.0 109.55 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 11.0 pt-20 . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.525 ' HB3' ' N ' ' A' ' 6' ' ' CYS . 8.7 m-20 -41.39 111.76 0.25 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.324 -0.86 . . . . 0.0 109.874 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 4.5 m-85 -88.09 -173.53 4.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.745 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . . . 63.58 40.18 8.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.527 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.31 -28.21 9.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . 139.85 -174.18 22.51 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 6.3 t -84.05 -17.66 39.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -1.109 . . . . 0.0 109.379 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.72 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.222 0.534 . . . . 0.0 109.74 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 8' ' ' THR . 7.4 t -40.0 120.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.077 -1.014 . . . . 0.0 110.231 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.29 -42.02 1.63 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.745 ' CE1' ' HB3' ' A' ' 3' ' ' ALA . 2.2 m-85 -111.9 152.17 28.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -1.166 . . . . 0.0 109.954 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.53 128.56 54.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 8.8 ttp85 -45.04 151.04 0.34 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.251 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.414 ' OG1' ' C ' ' A' ' 17' ' ' ARG . 7.6 p -125.01 141.61 52.02 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 -1.88 1.54 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.654 -0.654 . . . . 0.0 111.577 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 8.0 p-10 -93.64 21.49 6.33 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 52.77 46.08 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -160.01 -147.41 0.15 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.512 -0.993 . . . . 0.0 109.382 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -157.85 127.73 6.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.712 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -97.07 163.5 19.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.422 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.538 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 34.8 Cg_endo -79.17 127.76 7.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.292 1.995 . . . . 0.0 110.591 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 21' ' ' THR . 54.3 m -89.42 40.45 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 m-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 12.2 pt-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m-80 -51.22 106.61 0.14 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -0.93 . . . . 0.0 109.055 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -43.66 126.76 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 32.78 61.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.223 0.535 . . . . 0.0 110.544 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.24 49.12 81.24 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 1' ' ' ASN . . . -85.51 26.46 5.76 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 5.2 t -79.92 -21.41 43.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.233 . . . . 0.0 108.806 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.4 -148.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.452 0.644 . . . . 0.0 109.924 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 m -46.73 121.23 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.0 -41.9 1.66 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 4.7 m-85 -106.5 -168.92 1.48 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.442 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.496 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -153.32 105.37 2.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.017 . . . . 0.0 108.613 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.52 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -33.19 108.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.497 0.665 . . . . 0.0 110.824 -178.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.547 HG22 ' CA ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -89.42 153.72 20.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.405 -0.81 . . . . 0.0 109.165 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 1.27 0.57 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.733 -0.604 . . . . 0.0 111.874 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.5 ' OD1' HG23 ' A' ' 13' ' ' THR . 25.3 p30 -92.01 18.2 8.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 67.37 36.15 88.66 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -144.6 -141.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.567 -0.961 . . . . 0.0 109.58 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.547 ' CA ' HG22 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.91 139.54 18.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.316 -0.865 . . . . 0.0 109.354 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 18.7 ptmt -112.92 156.77 42.19 Favored Pre-proline 0 C--N 1.306 -1.321 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.03 143.05 25.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.265 1.977 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.01 50.57 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.489 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 5.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 6' ' ' CYS . 10.3 p30 -37.12 127.95 0.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.686 -0.634 . . . . 0.0 110.083 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.92 -158.03 0.64 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.68 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . . . 60.03 48.22 8.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.78 -23.22 29.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.438 ' HA2' ' OD1' ' A' ' 1' ' ' ASN . . . 110.07 -172.16 15.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 8.2 t -80.18 -20.31 45.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -1.119 . . . . 0.0 109.286 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.16 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.337 0.589 . . . . 0.0 109.792 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.6 m -46.24 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.747 ' O ' HG22 ' A' ' 21' ' ' THR . . . 155.35 -38.18 0.63 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.68 ' CE1' ' HB3' ' A' ' 3' ' ' ALA . 2.4 m-85 -115.49 152.3 33.23 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.491 -1.005 . . . . 0.0 109.142 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -93.6 114.93 27.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.751 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' LEU . 12.3 ttm180 -38.5 140.52 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.554 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.769 HG23 ' HA ' ' A' ' 18' ' ' CYS . 16.6 p -121.48 133.13 55.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.499 -0.75 . . . . 0.0 109.176 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 1.46 2.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.688 . . . . 0.0 111.524 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 6.1 p-10 -91.47 16.15 10.89 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.31 29.85 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -158.01 -154.06 0.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -1.099 . . . . 0.0 109.669 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.769 ' HA ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.27 132.7 13.77 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.177 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -98.94 -178.97 0.76 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.301 -0.874 . . . . 0.0 109.335 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.4 Cg_endo -81.44 133.11 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.524 2.15 . . . . 0.0 110.016 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 9' ' ' GLY . 14.9 t -85.77 44.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.691 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CD2' ' C ' ' A' ' 21' ' ' THR . 6.8 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.536 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 2.2 tp10 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.397 0.618 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.542 ' N ' ' HG3' ' A' ' 0' ' ' GLU . 0.3 OUTLIER -42.25 147.16 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.488 -0.758 . . . . 0.0 109.566 179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.74 -171.82 3.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 47.26 60.67 3.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.294 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.49 -35.53 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.42 -152.02 20.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 3.3 t -80.19 -20.98 43.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.535 -0.98 . . . . 0.0 109.54 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.67 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 8' ' ' THR . 9.7 t -46.89 129.97 11.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.667 -1.27 . . . . 0.0 109.206 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 116.03 -34.57 4.66 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.549 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 5.7 m-85 -124.39 153.43 41.88 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.287 -1.125 . . . . 0.0 109.429 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' ARG . 1.1 tp -107.95 117.61 34.58 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -37.3 133.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.758 . . . . 0.0 110.5 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 19' ' ' LYS . 43.2 p -107.88 137.67 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 2.2 0.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.615 -0.678 . . . . 0.0 111.852 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -96.76 19.08 13.08 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 71.38 47.19 36.95 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 4.0 mtp180 -157.81 -142.91 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.443 -1.034 . . . . 0.0 109.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -160.03 140.6 11.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.125 -0.984 . . . . 0.0 109.559 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 2.7 mtpt -100.64 171.58 5.35 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.346 -0.846 . . . . 0.0 109.297 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.513 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 36.2 Cg_endo -79.7 147.27 19.43 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.603 2.202 . . . . 0.0 110.169 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 21' ' ' THR . 80.0 m -87.47 33.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.037 -1.04 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' C ' ' O ' ' A' ' 21' ' ' THR . 65.3 m-85 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.822 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.458 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.306 0.574 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.455 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 4.3 m120 47.61 -168.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.503 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 3' ' ' ALA . 20.8 t80 -131.62 167.91 18.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.216 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.606 ' N ' ' CG ' ' A' ' 2' ' ' PHE . . . 60.55 60.61 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.44 -8.87 60.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 0' ' ' GLU . . . 96.77 -134.76 11.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' O ' ' O ' ' A' ' 7' ' ' ALA . 36.5 t -81.78 -17.98 45.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -1.09 . . . . 0.0 109.391 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -52.87 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 8' ' ' THR . 12.1 t -40.13 115.09 0.5 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 21' ' ' THR . . . 140.03 -37.01 1.76 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.8 m-85 -106.87 -170.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD23 ' H ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -138.97 -158.59 0.87 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.017 -1.052 . . . . 0.0 109.66 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.687 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.4 ttm-85 -103.52 118.46 36.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.822 -1.174 . . . . 0.0 110.438 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.453 ' OG1' ' C ' ' A' ' 17' ' ' ARG . 13.7 p -115.0 130.97 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 0.0 108.866 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.34 1.85 1.45 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.622 -0.674 . . . . 0.0 111.232 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -89.15 14.72 10.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.67 44.14 33.33 Favored Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -155.15 -146.88 0.19 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.505 -0.997 . . . . 0.0 109.021 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 55.8 m -144.59 148.7 34.69 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.27 -0.894 . . . . 0.0 108.943 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -97.29 129.29 32.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.544 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 19' ' ' LYS . 33.4 Cg_endo -75.82 126.45 9.45 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.265 1.977 . . . . 0.0 110.41 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 9' ' ' GLY . 1.7 t -88.8 52.8 2.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.2 -0.905 . . . . 0.0 109.979 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 1' ' ' ASN . 2.2 pt-20 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 0' ' ' GLU . 5.6 m120 74.29 45.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 1' ' ' ASN . 1.5 m-85 48.04 -171.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.586 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.87 13.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.27 36.29 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.4 178.18 11.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 11.1 t -79.89 -22.92 42.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -56.75 -150.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 8' ' ' THR . 12.8 t -42.38 119.1 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.09 . . . . 0.0 109.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 21' ' ' THR . . . 126.31 -34.19 3.28 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' HD22 ' A' ' 11' ' ' LEU . 5.1 m-85 -115.02 -178.51 3.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.24 . . . . 0.0 110.045 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -141.15 104.85 4.71 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.476 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 2.2 mtm180 -39.38 114.47 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 110.965 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 18' ' ' CYS . 1.2 p -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.5 6.51 0.2 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.648 -0.657 . . . . 0.0 112.408 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.495 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 46.6 p-10 -88.36 11.69 16.12 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 76.64 32.7 49.72 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 16' ' ' GLY . 4.6 mmt180 -154.41 -142.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -1.042 . . . . 0.0 108.732 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HA ' HG23 ' A' ' 13' ' ' THR . 32.1 m -153.16 152.7 31.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HG3' HG21 ' A' ' 13' ' ' THR . 12.6 mtpt -111.94 169.48 6.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 109.862 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 35.7 Cg_endo -79.07 130.8 9.56 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.612 2.208 . . . . 0.0 110.144 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 9' ' ' GLY . 14.4 t -92.56 56.09 2.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.487 ' OE2' ' HD3' ' A' ' 17' ' ' ARG . 5.7 pt-20 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 10' ' ' TYR . 15.7 m120 56.87 111.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.868 . . . . 0.0 109.675 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.29 -160.03 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.47 8.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.16 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.94 -42.29 1.2 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 1' ' ' ASN . . . 95.05 -162.07 23.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 7' ' ' ALA . 2.7 t -90.62 -26.65 19.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.442 -1.034 . . . . 0.0 108.946 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.27 -161.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.319 0.58 . . . . 0.0 109.849 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.671 ' O ' HG23 ' A' ' 8' ' ' THR . 6.8 t -40.1 115.04 0.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 109.874 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.5 -40.13 1.59 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' A' ' 1' ' ' ASN . 4.2 m-85 -107.04 -175.6 2.84 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.177 -1.19 . . . . 0.0 109.628 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -147.69 114.7 6.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -25.97 110.85 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.718 0.77 . . . . 0.0 112.317 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -85.84 149.48 25.21 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 2.16 0.98 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.674 -0.641 . . . . 0.0 111.486 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 59.5 p30 -95.24 18.45 12.35 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' C ' ' HG2' ' A' ' 17' ' ' ARG . . . 70.05 41.5 70.74 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HD3' ' OE2' ' A' ' 0' ' ' GLU . 10.3 mmt85 -151.53 -139.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.409 -1.054 . . . . 0.0 108.491 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 63.9 m -152.02 141.02 21.17 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 108.891 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.72 ' HB3' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -103.34 155.79 36.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -75.43 137.38 20.72 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.308 2.005 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 21' ' ' THR . 54.0 m -86.54 57.62 4.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' OXT' ' O ' ' A' ' 21' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 1' ' ' ASN . 9.0 tp10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 0' ' ' GLU . 11.8 m120 60.72 127.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.639 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -103.83 -155.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 109.241 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.88 28.29 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 109.852 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.37 -35.05 3.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 10' ' ' TYR . . . 114.46 178.64 18.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.571 ' HA ' ' CB ' ' A' ' 10' ' ' TYR . 6.8 t -79.99 -27.34 39.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.122 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -60.03 -141.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 m -45.89 132.8 8.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.758 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.38 -39.93 2.71 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.571 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.5 m-85 -104.24 -167.07 1.31 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.205 -1.173 . . . . 0.0 109.856 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -143.62 101.63 3.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 108.753 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -35.85 113.0 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.614 0.721 . . . . 0.0 111.145 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 11' ' ' LEU . 23.6 p -104.83 130.06 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.52 4.47 1.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 111.105 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.94 1.81 25.92 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' ARG . . . 96.38 24.54 14.01 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 13.5 mtt180 -159.95 -146.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -1.113 . . . . 0.0 108.938 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -143.42 157.79 44.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 109.6 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' C ' ' CD2' ' A' ' 10' ' ' TYR . 3.6 ttpt -112.97 135.7 21.69 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.3 Cg_endo -74.84 143.68 29.94 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.043 1.829 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -85.21 52.67 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.718 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.557 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.291 0.567 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.569 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -114.8 -176.74 2.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -0.901 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 2' ' ' PHE . . . 60.79 50.83 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 109.327 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.64 -32.52 7.31 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.12 -140.36 15.28 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 4.3 t -79.99 -23.19 41.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 108.953 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.68 -156.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.351 0.596 . . . . 0.0 109.697 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' ALA . 20.7 m -42.58 115.13 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.677 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 134.09 -35.48 2.23 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' OH ' ' CE1' ' A' ' 2' ' ' PHE . 4.1 m-85 -116.92 152.86 33.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.244 -1.15 . . . . 0.0 109.827 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 43.5 mt -95.2 167.33 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 12' ' ' ARG . 1.5 ptp180 -86.71 114.95 23.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.039 -1.038 . . . . 0.0 110.043 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 19' ' ' LYS . 3.6 p -89.44 135.32 33.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.062 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.11 -0.64 3.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.751 -0.593 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.476 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -90.88 16.51 9.27 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.33 50.35 21.93 Favored Glycine 0 N--CA 1.475 1.254 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.0 -157.8 0.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 0.0 109.765 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HA ' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -140.82 130.51 24.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.408 -0.808 . . . . 0.0 109.359 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -97.52 176.77 1.9 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 108.87 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.0 Cg_endo -80.04 140.19 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.197 1.932 . . . . 0.0 109.913 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 21' ' ' THR . 94.1 m -85.04 30.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.098 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' THR . 3.8 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.693 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -129.49 -166.24 1.63 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 44.48 70.29 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.01 15.13 78.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.48 -127.05 33.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 14.9 t -83.97 -17.89 39.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.7 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.314 0.578 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 7' ' ' ALA . 16.8 m -42.55 119.77 1.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.986 -1.072 . . . . 0.0 110.103 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.22 -37.86 2.54 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.583 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 3.1 m-85 -114.39 160.79 18.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -1.123 . . . . 0.0 109.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 1.7 tp -114.84 172.02 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.46 150.89 25.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.721 -1.237 . . . . 0.0 110.527 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 18' ' ' CYS . 73.0 p -138.06 135.12 35.53 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 3.01 0.57 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 112.093 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p-10 -91.77 16.29 11.08 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.825 -1.172 . . . . 0.0 107.869 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.06 38.42 55.32 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.15 -157.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -1.073 . . . . 0.0 109.241 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 90.1 m -138.8 151.75 47.31 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 16.7 mtpt -103.64 166.27 12.03 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.99 132.88 9.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.404 2.069 . . . . 0.0 110.352 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.591 ' O ' HG22 ' A' ' 21' ' ' THR . 94.7 m -86.47 57.48 4.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.067 -1.021 . . . . 0.0 109.55 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.525 ' HB3' ' N ' ' A' ' 6' ' ' CYS . 8.7 m-20 . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.281 0.562 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 4.5 m-85 -88.09 -173.53 4.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.745 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . . . 63.58 40.18 8.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.527 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.31 -28.21 9.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . 139.85 -174.18 22.51 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 6.3 t -84.05 -17.66 39.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -1.109 . . . . 0.0 109.379 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.72 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.222 0.534 . . . . 0.0 109.74 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 8' ' ' THR . 7.4 t -40.0 120.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.077 -1.014 . . . . 0.0 110.231 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.29 -42.02 1.63 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.745 ' CE1' ' HB3' ' A' ' 3' ' ' ALA . 2.2 m-85 -111.9 152.17 28.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -1.166 . . . . 0.0 109.954 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.53 128.56 54.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 8.8 ttp85 -45.04 151.04 0.34 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.251 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.414 ' OG1' ' C ' ' A' ' 17' ' ' ARG . 7.6 p -125.01 141.61 52.02 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 -1.88 1.54 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.654 -0.654 . . . . 0.0 111.577 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 8.0 p-10 -93.64 21.49 6.33 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 52.77 46.08 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -160.01 -147.41 0.15 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.512 -0.993 . . . . 0.0 109.382 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -157.85 127.73 6.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.712 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -97.07 163.5 19.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.422 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.538 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 34.8 Cg_endo -79.17 127.76 7.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.292 1.995 . . . . 0.0 110.591 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 21' ' ' THR . 54.3 m -89.42 40.45 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 m-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m-80 . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -43.66 126.76 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 32.78 61.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.223 0.535 . . . . 0.0 110.544 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.24 49.12 81.24 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 1' ' ' ASN . . . -85.51 26.46 5.76 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 5.2 t -79.92 -21.41 43.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.233 . . . . 0.0 108.806 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.4 -148.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.452 0.644 . . . . 0.0 109.924 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 m -46.73 121.23 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.0 -41.9 1.66 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 4.7 m-85 -106.5 -168.92 1.48 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.442 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.496 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -153.32 105.37 2.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.017 . . . . 0.0 108.613 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.52 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -33.19 108.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.497 0.665 . . . . 0.0 110.824 -178.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.547 HG22 ' CA ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -89.42 153.72 20.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.405 -0.81 . . . . 0.0 109.165 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 1.27 0.57 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.733 -0.604 . . . . 0.0 111.874 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.5 ' OD1' HG23 ' A' ' 13' ' ' THR . 25.3 p30 -92.01 18.2 8.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 67.37 36.15 88.66 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -144.6 -141.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.567 -0.961 . . . . 0.0 109.58 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.547 ' CA ' HG22 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.91 139.54 18.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.316 -0.865 . . . . 0.0 109.354 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 18.7 ptmt -112.92 156.77 42.19 Favored Pre-proline 0 C--N 1.306 -1.321 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.03 143.05 25.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.265 1.977 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.01 50.57 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.489 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 6' ' ' CYS . 10.3 p30 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.285 0.564 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.92 -158.03 0.64 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.68 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . . . 60.03 48.22 8.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.78 -23.22 29.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.438 ' HA2' ' OD1' ' A' ' 1' ' ' ASN . . . 110.07 -172.16 15.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 8.2 t -80.18 -20.31 45.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -1.119 . . . . 0.0 109.286 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.16 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.337 0.589 . . . . 0.0 109.792 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.6 m -46.24 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.747 ' O ' HG22 ' A' ' 21' ' ' THR . . . 155.35 -38.18 0.63 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.68 ' CE1' ' HB3' ' A' ' 3' ' ' ALA . 2.4 m-85 -115.49 152.3 33.23 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.491 -1.005 . . . . 0.0 109.142 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -93.6 114.93 27.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.751 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' LEU . 12.3 ttm180 -38.5 140.52 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.554 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.769 HG23 ' HA ' ' A' ' 18' ' ' CYS . 16.6 p -121.48 133.13 55.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.499 -0.75 . . . . 0.0 109.176 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 1.46 2.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.688 . . . . 0.0 111.524 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 6.1 p-10 -91.47 16.15 10.89 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.31 29.85 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -158.01 -154.06 0.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -1.099 . . . . 0.0 109.669 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.769 ' HA ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.27 132.7 13.77 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.177 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -98.94 -178.97 0.76 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.301 -0.874 . . . . 0.0 109.335 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.4 Cg_endo -81.44 133.11 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.524 2.15 . . . . 0.0 110.016 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 9' ' ' GLY . 14.9 t -85.77 44.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.691 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CD2' ' C ' ' A' ' 21' ' ' THR . 6.8 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.536 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.74 -171.82 3.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 47.26 60.67 3.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.294 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.49 -35.53 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.42 -152.02 20.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 3.3 t -80.19 -20.98 43.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.535 -0.98 . . . . 0.0 109.54 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.67 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 8' ' ' THR . 9.7 t -46.89 129.97 11.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.667 -1.27 . . . . 0.0 109.206 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 116.03 -34.57 4.66 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.549 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 5.7 m-85 -124.39 153.43 41.88 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.287 -1.125 . . . . 0.0 109.429 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' ARG . 1.1 tp -107.95 117.61 34.58 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.481 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -37.3 133.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.758 . . . . 0.0 110.5 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 19' ' ' LYS . 43.2 p -107.88 137.67 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 2.2 0.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.615 -0.678 . . . . 0.0 111.852 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -96.76 19.08 13.08 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 71.38 47.19 36.95 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 4.0 mtp180 -157.81 -142.91 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.443 -1.034 . . . . 0.0 109.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -160.03 140.6 11.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.125 -0.984 . . . . 0.0 109.559 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 2.7 mtpt -100.64 171.58 5.35 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.346 -0.846 . . . . 0.0 109.297 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.513 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 36.2 Cg_endo -79.7 147.27 19.43 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.603 2.202 . . . . 0.0 110.169 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 21' ' ' THR . 80.0 m -87.47 33.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.037 -1.04 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' C ' ' O ' ' A' ' 21' ' ' THR . 65.3 m-85 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.822 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.455 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 75.6 m-20 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.322 0.582 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 3' ' ' ALA . 20.8 t80 -131.62 167.91 18.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.216 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.606 ' N ' ' CG ' ' A' ' 2' ' ' PHE . . . 60.55 60.61 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.44 -8.87 60.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . 96.77 -134.76 11.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.494 ' O ' ' O ' ' A' ' 7' ' ' ALA . 36.5 t -81.78 -17.98 45.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -1.09 . . . . 0.0 109.391 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -52.87 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 8' ' ' THR . 12.1 t -40.13 115.09 0.5 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 21' ' ' THR . . . 140.03 -37.01 1.76 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.8 m-85 -106.87 -170.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.687 HD23 ' H ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -138.97 -158.59 0.87 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.017 -1.052 . . . . 0.0 109.66 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.687 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.4 ttm-85 -103.52 118.46 36.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.822 -1.174 . . . . 0.0 110.438 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.453 ' OG1' ' C ' ' A' ' 17' ' ' ARG . 13.7 p -115.0 130.97 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 0.0 108.866 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.34 1.85 1.45 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.622 -0.674 . . . . 0.0 111.232 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -89.15 14.72 10.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.67 44.14 33.33 Favored Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -155.15 -146.88 0.19 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.505 -0.997 . . . . 0.0 109.021 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 55.8 m -144.59 148.7 34.69 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.27 -0.894 . . . . 0.0 108.943 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -97.29 129.29 32.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.544 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 19' ' ' LYS . 33.4 Cg_endo -75.82 126.45 9.45 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.265 1.977 . . . . 0.0 110.41 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 9' ' ' GLY . 1.7 t -88.8 52.8 2.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.2 -0.905 . . . . 0.0 109.979 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 10' ' ' TYR . 5.6 m120 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 1' ' ' ASN . 1.5 m-85 48.04 -171.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.586 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.87 13.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.27 36.29 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.4 178.18 11.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 11.1 t -79.89 -22.92 42.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -56.75 -150.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 8' ' ' THR . 12.8 t -42.38 119.1 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.09 . . . . 0.0 109.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 21' ' ' THR . . . 126.31 -34.19 3.28 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' HD22 ' A' ' 11' ' ' LEU . 5.1 m-85 -115.02 -178.51 3.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.24 . . . . 0.0 110.045 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -141.15 104.85 4.71 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.476 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 2.2 mtm180 -39.38 114.47 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 110.965 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 18' ' ' CYS . 1.2 p -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.5 6.51 0.2 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.648 -0.657 . . . . 0.0 112.408 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.495 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 46.6 p-10 -88.36 11.69 16.12 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 76.64 32.7 49.72 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 16' ' ' GLY . 4.6 mmt180 -154.41 -142.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -1.042 . . . . 0.0 108.732 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HA ' HG23 ' A' ' 13' ' ' THR . 32.1 m -153.16 152.7 31.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HG3' HG21 ' A' ' 13' ' ' THR . 12.6 mtpt -111.94 169.48 6.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 109.862 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 35.7 Cg_endo -79.07 130.8 9.56 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.612 2.208 . . . . 0.0 110.144 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 9' ' ' GLY . 14.4 t -92.56 56.09 2.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 10' ' ' TYR . 15.7 m120 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.282 0.563 . . . . 0.0 109.675 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.29 -160.03 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.47 8.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.16 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.94 -42.29 1.2 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 1' ' ' ASN . . . 95.05 -162.07 23.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 7' ' ' ALA . 2.7 t -90.62 -26.65 19.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.442 -1.034 . . . . 0.0 108.946 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.27 -161.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.319 0.58 . . . . 0.0 109.849 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.671 ' O ' HG23 ' A' ' 8' ' ' THR . 6.8 t -40.1 115.04 0.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 109.874 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.5 -40.13 1.59 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' A' ' 1' ' ' ASN . 4.2 m-85 -107.04 -175.6 2.84 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.177 -1.19 . . . . 0.0 109.628 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -147.69 114.7 6.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -25.97 110.85 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.718 0.77 . . . . 0.0 112.317 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -85.84 149.48 25.21 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 2.16 0.98 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.674 -0.641 . . . . 0.0 111.486 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 59.5 p30 -95.24 18.45 12.35 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.434 ' C ' ' HG2' ' A' ' 17' ' ' ARG . . . 70.05 41.5 70.74 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.481 ' O ' ' SG ' ' A' ' 18' ' ' CYS . 10.3 mmt85 -151.53 -139.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.409 -1.054 . . . . 0.0 108.491 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 63.9 m -152.02 141.02 21.17 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 108.891 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.72 ' HB3' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -103.34 155.79 36.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -75.43 137.38 20.72 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.308 2.005 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 21' ' ' THR . 54.0 m -86.54 57.62 4.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.455 ' OXT' ' O ' ' A' ' 21' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ASN . . . . . 0.461 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 25.9 m-80 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.21 0.529 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -103.83 -155.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 109.241 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.88 28.29 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 109.852 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.37 -35.05 3.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 10' ' ' TYR . . . 114.46 178.64 18.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.571 ' HA ' ' CB ' ' A' ' 10' ' ' TYR . 6.8 t -79.99 -27.34 39.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.122 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -60.03 -141.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 m -45.89 132.8 8.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.758 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.38 -39.93 2.71 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.571 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.5 m-85 -104.24 -167.07 1.31 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.205 -1.173 . . . . 0.0 109.856 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -143.62 101.63 3.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 108.753 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -35.85 113.0 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.614 0.721 . . . . 0.0 111.145 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 11' ' ' LEU . 23.6 p -104.83 130.06 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.52 4.47 1.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 111.105 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.94 1.81 25.92 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' ARG . . . 96.38 24.54 14.01 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 13.5 mtt180 -159.95 -146.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -1.113 . . . . 0.0 108.938 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -143.42 157.79 44.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 109.6 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' C ' ' CD2' ' A' ' 10' ' ' TYR . 3.6 ttpt -112.97 135.7 21.69 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.3 Cg_endo -74.84 143.68 29.94 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.043 1.829 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -85.21 52.67 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.718 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.557 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.498 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 9.0 tp10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.388 0.613 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.498 ' N ' ' HG3' ' A' ' 0' ' ' GLU . 46.3 m-20 -43.28 148.63 0.28 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 109.641 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.569 ' CE1' ' OH ' ' A' ' 10' ' ' TYR . 0.2 OUTLIER -114.8 -176.74 2.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -0.901 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 2' ' ' PHE . . . 60.79 50.83 5.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 109.327 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.64 -32.52 7.31 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 107.12 -140.36 15.28 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 4.3 t -79.99 -23.19 41.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.306 -1.114 . . . . 0.0 108.953 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.68 -156.98 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.351 0.596 . . . . 0.0 109.697 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.43 ' C ' ' O ' ' A' ' 7' ' ' ALA . 20.7 m -42.58 115.13 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.118 -0.989 . . . . 0.0 109.677 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 134.09 -35.48 2.23 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' OH ' ' CE1' ' A' ' 2' ' ' PHE . 4.1 m-85 -116.92 152.86 33.63 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.244 -1.15 . . . . 0.0 109.827 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB2' ' HG2' ' A' ' 19' ' ' LYS . 43.5 mt -95.2 167.33 11.43 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 12' ' ' ARG . 1.5 ptp180 -86.71 114.95 23.82 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.039 -1.038 . . . . 0.0 110.043 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 19' ' ' LYS . 3.6 p -89.44 135.32 33.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.815 . . . . 0.0 109.062 179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.11 -0.64 3.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.751 -0.593 . . . . 0.0 111.072 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.476 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 0.8 OUTLIER -90.88 16.51 9.27 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.33 50.35 21.93 Favored Glycine 0 N--CA 1.475 1.254 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.0 -157.8 0.59 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 0.0 109.765 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.497 ' HA ' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -140.82 130.51 24.19 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.408 -0.808 . . . . 0.0 109.359 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -97.52 176.77 1.9 Allowed Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 108.87 179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.0 Cg_endo -80.04 140.19 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.197 1.932 . . . . 0.0 109.913 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.775 HG22 ' O ' ' A' ' 21' ' ' THR . 94.1 m -85.04 30.06 0.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.073 -1.017 . . . . 0.0 110.098 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' C ' ' O ' ' A' ' 21' ' ' THR . 3.8 m-85 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.693 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 1' ' ' ASN . 16.9 tp10 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.188 0.518 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.433 ' H ' ' HG3' ' A' ' 0' ' ' GLU . 28.1 p-10 -69.93 152.56 44.33 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.167 -0.958 . . . . 0.0 109.489 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -129.49 -166.24 1.63 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 44.48 70.29 0.35 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 109.354 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.01 15.13 78.53 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 64.48 -127.05 33.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 14.9 t -83.97 -17.89 39.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -1.142 . . . . 0.0 109.419 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.7 -152.56 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.314 0.578 . . . . 0.0 109.966 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 7' ' ' ALA . 16.8 m -42.55 119.77 1.52 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.986 -1.072 . . . . 0.0 110.103 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.22 -37.86 2.54 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.583 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 3.1 m-85 -114.39 160.79 18.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -1.123 . . . . 0.0 109.959 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 18' ' ' CYS . 1.7 tp -114.84 172.02 7.3 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.46 150.89 25.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.721 -1.237 . . . . 0.0 110.527 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 18' ' ' CYS . 73.0 p -138.06 135.12 35.53 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.73 3.01 0.57 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.678 -0.639 . . . . 0.0 112.093 -178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HB2' ' A' ' 17' ' ' ARG . 6.2 p-10 -91.77 16.29 11.08 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 120.825 -1.172 . . . . 0.0 107.869 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.06 38.42 55.32 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -160.15 -157.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -1.073 . . . . 0.0 109.241 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 90.1 m -138.8 151.75 47.31 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.804 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.583 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 16.7 mtpt -103.64 166.27 12.03 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.34 -0.85 . . . . 0.0 109.715 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.99 132.88 9.75 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.404 2.069 . . . . 0.0 110.352 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 21' ' ' THR . 94.7 m -86.47 57.48 4.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.067 -1.021 . . . . 0.0 109.55 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.566 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 11.0 pt-20 . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.525 ' HB3' ' N ' ' A' ' 6' ' ' CYS . 8.7 m-20 -41.39 111.76 0.25 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.324 -0.86 . . . . 0.0 109.874 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 4.5 m-85 -88.09 -173.53 4.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.591 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.745 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . . . 63.58 40.18 8.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.527 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.31 -28.21 9.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 1' ' ' ASN . . . 139.85 -174.18 22.51 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 6.3 t -84.05 -17.66 39.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.315 -1.109 . . . . 0.0 109.379 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.72 -158.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.222 0.534 . . . . 0.0 109.74 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 8' ' ' THR . 7.4 t -40.0 120.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.077 -1.014 . . . . 0.0 110.231 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.29 -42.02 1.63 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.745 ' CE1' ' HB3' ' A' ' 3' ' ' ALA . 2.2 m-85 -111.9 152.17 28.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.218 -1.166 . . . . 0.0 109.954 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.53 128.56 54.92 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 8.8 ttp85 -45.04 151.04 0.34 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 110.251 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.414 ' OG1' ' C ' ' A' ' 17' ' ' ARG . 7.6 p -125.01 141.61 52.02 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.76 -1.88 1.54 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.654 -0.654 . . . . 0.0 111.577 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 8.0 p-10 -93.64 21.49 6.33 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.73 52.77 46.08 Favored Glycine 0 N--CA 1.476 1.329 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -160.01 -147.41 0.15 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.512 -0.993 . . . . 0.0 109.382 -179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -157.85 127.73 6.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.121 -0.987 . . . . 0.0 109.712 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -97.07 163.5 19.85 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.39 -0.819 . . . . 0.0 109.422 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.538 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 34.8 Cg_endo -79.17 127.76 7.78 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.292 1.995 . . . . 0.0 110.591 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 21' ' ' THR . 54.3 m -89.42 40.45 0.99 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.372 -0.83 . . . . 0.0 109.737 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.558 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 3.0 m-30 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.489 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 12.2 pt-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 18' ' ' CYS . 1.8 m-80 -51.22 106.61 0.14 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.211 -0.93 . . . . 0.0 109.055 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 3' ' ' ALA . 0.2 OUTLIER -43.66 126.76 4.69 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 110.111 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.481 ' C ' ' O ' ' A' ' 2' ' ' PHE . . . 32.78 61.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.223 0.535 . . . . 0.0 110.544 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.24 49.12 81.24 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 1' ' ' ASN . . . -85.51 26.46 5.76 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.569 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 5.2 t -79.92 -21.41 43.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.105 -1.233 . . . . 0.0 108.806 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.4 -148.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.452 0.644 . . . . 0.0 109.924 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 m -46.73 121.23 3.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.0 -41.9 1.66 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.569 ' HB2' ' HA ' ' A' ' 6' ' ' CYS . 4.7 m-85 -106.5 -168.92 1.48 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.313 -1.11 . . . . 0.0 109.442 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.496 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -153.32 105.37 2.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.074 -1.017 . . . . 0.0 108.613 -179.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.52 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -33.19 108.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.497 0.665 . . . . 0.0 110.824 -178.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.547 HG22 ' CA ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER -89.42 153.72 20.61 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.405 -0.81 . . . . 0.0 109.165 179.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.5 1.27 0.57 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.733 -0.604 . . . . 0.0 111.874 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.5 ' OD1' HG23 ' A' ' 13' ' ' THR . 25.3 p30 -92.01 18.2 8.27 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 67.37 36.15 88.66 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 108.917 -1.673 . . . . 0.0 108.917 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 0.4 OUTLIER -144.6 -141.93 0.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.567 -0.961 . . . . 0.0 109.58 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.547 ' CA ' HG22 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.91 139.54 18.8 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.316 -0.865 . . . . 0.0 109.354 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 10' ' ' TYR . 18.7 ptmt -112.92 156.77 42.19 Favored Pre-proline 0 C--N 1.306 -1.321 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -76.03 143.05 25.51 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.265 1.977 . . . . 0.0 110.143 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.01 50.57 1.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.853 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.489 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 5.1 tt0 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 6' ' ' CYS . 10.3 p30 -37.12 127.95 0.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.686 -0.634 . . . . 0.0 110.083 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.92 -158.03 0.64 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.297 -0.877 . . . . 0.0 109.54 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.68 ' HB3' ' CE1' ' A' ' 10' ' ' TYR . . . 60.03 48.22 8.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 109.387 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.78 -23.22 29.67 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.438 ' HA2' ' OD1' ' A' ' 1' ' ' ASN . . . 110.07 -172.16 15.49 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.605 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 8.2 t -80.18 -20.31 45.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.298 -1.119 . . . . 0.0 109.286 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -55.16 -160.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.337 0.589 . . . . 0.0 109.792 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 46.6 m -46.24 101.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.747 ' O ' HG22 ' A' ' 21' ' ' THR . . . 155.35 -38.18 0.63 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.844 -1.702 . . . . 0.0 108.844 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.68 ' CE1' ' HB3' ' A' ' 3' ' ' ALA . 2.4 m-85 -115.49 152.3 33.23 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.491 -1.005 . . . . 0.0 109.142 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -93.6 114.93 27.38 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 108.751 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' LEU . 12.3 ttm180 -38.5 140.52 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.554 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.769 HG23 ' HA ' ' A' ' 18' ' ' CYS . 16.6 p -121.48 133.13 55.04 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.499 -0.75 . . . . 0.0 109.176 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.4 1.46 2.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.6 -0.688 . . . . 0.0 111.524 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' OD1' ' HB ' ' A' ' 13' ' ' THR . 6.1 p-10 -91.47 16.15 10.89 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.12 44.31 29.85 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' OD2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -158.01 -154.06 0.42 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.331 -1.099 . . . . 0.0 109.669 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.769 ' HA ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -152.27 132.7 13.77 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.414 -0.804 . . . . 0.0 109.177 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -98.94 -178.97 0.76 Allowed Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.301 -0.874 . . . . 0.0 109.335 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 19' ' ' LYS . 36.4 Cg_endo -81.44 133.11 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.524 2.15 . . . . 0.0 110.016 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 9' ' ' GLY . 14.9 t -85.77 44.66 1.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.094 -1.004 . . . . 0.0 109.691 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' CD2' ' C ' ' A' ' 21' ' ' THR . 6.8 m-85 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.536 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 1' ' ' ASN . 2.2 tp10 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.397 0.618 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.542 ' N ' ' HG3' ' A' ' 0' ' ' GLU . 0.3 OUTLIER -42.25 147.16 0.26 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.488 -0.758 . . . . 0.0 109.566 179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.74 -171.82 3.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.544 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 47.26 60.67 3.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.262 -0.899 . . . . 0.0 109.294 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 107.49 -35.53 4.95 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.42 -152.02 20.23 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 3.3 t -80.19 -20.98 43.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.535 -0.98 . . . . 0.0 109.54 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -57.67 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 8' ' ' THR . 9.7 t -46.89 129.97 11.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.667 -1.27 . . . . 0.0 109.206 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' O ' ' OG1' ' A' ' 21' ' ' THR . . . 116.03 -34.57 4.66 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.549 ' CD2' ' O ' ' A' ' 19' ' ' LYS . 5.7 m-85 -124.39 153.43 41.88 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.287 -1.125 . . . . 0.0 109.429 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' C ' ' A' ' 12' ' ' ARG . 1.1 tp -107.95 117.61 34.58 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -37.3 133.6 0.68 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.488 -0.758 . . . . 0.0 110.5 -178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 19' ' ' LYS . 43.2 p -107.88 137.67 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.42 2.2 0.95 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.615 -0.678 . . . . 0.0 111.852 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.3 p30 -96.76 19.08 13.08 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' HG2' ' A' ' 17' ' ' ARG . . . 71.38 47.19 36.95 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 16' ' ' GLY . 4.0 mtp180 -157.81 -142.91 0.1 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.443 -1.034 . . . . 0.0 109.342 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' ' HB3' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -160.03 140.6 11.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.125 -0.984 . . . . 0.0 109.559 179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' O ' ' CD2' ' A' ' 10' ' ' TYR . 2.7 mtpt -100.64 171.58 5.35 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.346 -0.846 . . . . 0.0 109.297 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.513 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 36.2 Cg_endo -79.7 147.27 19.43 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.603 2.202 . . . . 0.0 110.169 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.806 HG22 ' O ' ' A' ' 21' ' ' THR . 80.0 m -87.47 33.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.037 -1.04 . . . . 0.0 109.59 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' C ' ' O ' ' A' ' 21' ' ' THR . 65.3 m-85 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.822 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.458 ' O ' ' HA2' ' A' ' 5' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.306 0.574 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.455 ' HB2' ' HA2' ' A' ' 5' ' ' GLY . 75.6 m-20 47.61 -168.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.503 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.606 ' CG ' ' N ' ' A' ' 3' ' ' ALA . 20.8 t80 -131.62 167.91 18.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.216 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.606 ' N ' ' CG ' ' A' ' 2' ' ' PHE . . . 60.55 60.61 1.92 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.451 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.44 -8.87 60.26 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 0' ' ' GLU . . . 96.77 -134.76 11.92 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' O ' ' O ' ' A' ' 7' ' ' ALA . 36.5 t -81.78 -17.98 45.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.348 -1.09 . . . . 0.0 109.391 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -52.87 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 8' ' ' THR . 12.1 t -40.13 115.09 0.5 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.2 -0.937 . . . . 0.0 109.567 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 21' ' ' THR . . . 140.03 -37.01 1.76 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.614 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 3.8 m-85 -106.87 -170.07 1.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -1.182 . . . . 0.0 109.425 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD23 ' H ' ' A' ' 12' ' ' ARG . 0.2 OUTLIER -138.97 -158.59 0.87 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.017 -1.052 . . . . 0.0 109.66 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.687 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.4 ttm-85 -103.52 118.46 36.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.822 -1.174 . . . . 0.0 110.438 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.453 ' OG1' ' C ' ' A' ' 17' ' ' ARG . 13.7 p -115.0 130.97 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.87 . . . . 0.0 108.866 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.34 1.85 1.45 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.622 -0.674 . . . . 0.0 111.232 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -89.15 14.72 10.17 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 73.67 44.14 33.33 Favored Glycine 0 N--CA 1.475 1.256 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' OG1' ' A' ' 13' ' ' THR . 0.0 OUTLIER -155.15 -146.88 0.19 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.505 -0.997 . . . . 0.0 109.021 -179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 55.8 m -144.59 148.7 34.69 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.27 -0.894 . . . . 0.0 108.943 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.557 ' O ' ' N ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -97.29 129.29 32.36 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.091 -1.006 . . . . 0.0 110.544 -178.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD2' ' HG2' ' A' ' 19' ' ' LYS . 33.4 Cg_endo -75.82 126.45 9.45 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.265 1.977 . . . . 0.0 110.41 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 9' ' ' GLY . 1.7 t -88.8 52.8 2.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.689 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.557 ' N ' ' CD1' ' A' ' 22' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 118.2 -0.905 . . . . 0.0 109.979 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 1' ' ' ASN . 2.2 pt-20 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 0' ' ' GLU . 5.6 m120 74.29 45.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.404 ' O ' ' O ' ' A' ' 1' ' ' ASN . 1.5 m-85 48.04 -171.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.586 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.87 13.99 1.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.179 -0.951 . . . . 0.0 110.374 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.47 -10.27 36.29 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.4 178.18 11.29 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 10' ' ' TYR . 11.1 t -79.89 -22.92 42.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -1.084 . . . . 0.0 109.442 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -56.75 -150.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.77 -0.581 . . . . 0.0 109.839 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 8' ' ' THR . 12.8 t -42.38 119.1 1.31 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.957 -1.09 . . . . 0.0 109.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.695 ' O ' HG22 ' A' ' 21' ' ' THR . . . 126.31 -34.19 3.28 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.679 ' O ' HD22 ' A' ' 11' ' ' LEU . 5.1 m-85 -115.02 -178.51 3.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.093 -1.24 . . . . 0.0 110.045 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 10' ' ' TYR . 0.4 OUTLIER -141.15 104.85 4.71 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.476 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 2.2 mtm180 -39.38 114.47 0.41 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.458 -0.776 . . . . 0.0 110.965 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.527 HG23 ' HA ' ' A' ' 18' ' ' CYS . 1.2 p -99.44 153.85 18.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.5 6.51 0.2 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.648 -0.657 . . . . 0.0 112.408 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.495 ' OD1' ' OG1' ' A' ' 13' ' ' THR . 46.6 p-10 -88.36 11.69 16.12 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' O ' ' NE ' ' A' ' 17' ' ' ARG . . . 76.64 32.7 49.72 Favored Glycine 0 C--O 1.214 -1.131 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.516 ' NE ' ' O ' ' A' ' 16' ' ' GLY . 4.6 mmt180 -154.41 -142.54 0.11 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.429 -1.042 . . . . 0.0 108.732 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.527 ' HA ' HG23 ' A' ' 13' ' ' THR . 32.1 m -153.16 152.7 31.55 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HG3' HG21 ' A' ' 13' ' ' THR . 12.6 mtpt -111.94 169.48 6.29 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 109.862 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HD2' ' HE3' ' A' ' 19' ' ' LYS . 35.7 Cg_endo -79.07 130.8 9.56 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.612 2.208 . . . . 0.0 110.144 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 9' ' ' GLY . 14.4 t -92.56 56.09 2.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.225 -0.922 . . . . 0.0 109.666 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.435 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.487 ' OE2' ' HD3' ' A' ' 17' ' ' ARG . 5.7 pt-20 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.553 ' HB3' ' CE2' ' A' ' 10' ' ' TYR . 15.7 m120 56.87 111.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.868 . . . . 0.0 109.675 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.29 -160.03 0.74 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.92 . . . . 0.0 109.268 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.47 8.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.16 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.94 -42.29 1.2 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 1' ' ' ASN . . . 95.05 -162.07 23.74 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.503 ' O ' ' O ' ' A' ' 7' ' ' ALA . 2.7 t -90.62 -26.65 19.54 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.442 -1.034 . . . . 0.0 108.946 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -54.27 -161.13 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.319 0.58 . . . . 0.0 109.849 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.671 ' O ' HG23 ' A' ' 8' ' ' THR . 6.8 t -40.1 115.04 0.5 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.21 -0.931 . . . . 0.0 109.874 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 135.5 -40.13 1.59 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' A' ' 1' ' ' ASN . 4.2 m-85 -107.04 -175.6 2.84 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.177 -1.19 . . . . 0.0 109.628 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD11 ' HD2' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -147.69 114.7 6.15 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -25.97 110.85 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.718 0.77 . . . . 0.0 112.317 -178.777 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.72 HG23 ' HB3' ' A' ' 19' ' ' LYS . 0.7 OUTLIER -85.84 149.48 25.21 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.46 2.16 0.98 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.674 -0.641 . . . . 0.0 111.486 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' C ' ' OD1' ' A' ' 15' ' ' ASP . 59.5 p30 -95.24 18.45 12.35 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.434 ' C ' ' HG2' ' A' ' 17' ' ' ARG . . . 70.05 41.5 70.74 Favored Glycine 0 N--CA 1.476 1.326 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.487 ' HD3' ' OE2' ' A' ' 0' ' ' GLU . 10.3 mmt85 -151.53 -139.02 0.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.409 -1.054 . . . . 0.0 108.491 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 10' ' ' TYR . 63.9 m -152.02 141.02 21.17 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.367 -0.833 . . . . 0.0 108.891 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.72 ' HB3' HG23 ' A' ' 13' ' ' THR . 0.0 OUTLIER -103.34 155.79 36.3 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.215 -0.928 . . . . 0.0 109.588 -179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.477 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.6 Cg_endo -75.43 137.38 20.72 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.308 2.005 . . . . 0.0 110.309 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 21' ' ' THR . 54.0 m -86.54 57.62 4.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.698 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.455 ' OXT' ' O ' ' A' ' 21' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.386 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' A' ' 1' ' ' ASN . 9.0 tp10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 0' ' ' GLU . 25.9 m-80 60.72 127.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.639 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -103.83 -155.48 0.53 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.107 -0.995 . . . . 0.0 109.241 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.88 28.29 15.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.203 -0.936 . . . . 0.0 109.852 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 123.37 -35.05 3.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.498 ' O ' ' CD1' ' A' ' 10' ' ' TYR . . . 114.46 178.64 18.98 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.571 ' HA ' ' CB ' ' A' ' 10' ' ' TYR . 6.8 t -79.99 -27.34 39.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.309 -1.112 . . . . 0.0 109.122 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 6' ' ' CYS . . . -60.03 -141.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.0 m -45.89 132.8 8.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.817 -1.177 . . . . 0.0 109.758 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.38 -39.93 2.71 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.571 ' CB ' ' HA ' ' A' ' 6' ' ' CYS . 1.5 m-85 -104.24 -167.07 1.31 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.205 -1.173 . . . . 0.0 109.856 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 13' ' ' THR . 0.1 OUTLIER -143.62 101.63 3.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 108.753 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' HA ' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -35.85 113.0 0.19 Allowed 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.614 0.721 . . . . 0.0 111.145 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 11' ' ' LEU . 23.6 p -104.83 130.06 53.01 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.52 4.47 1.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.479 -0.763 . . . . 0.0 111.105 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.3 p-10 -79.94 1.81 25.92 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' O ' ' CG ' ' A' ' 17' ' ' ARG . . . 96.38 24.54 14.01 Favored Glycine 0 N--CA 1.473 1.115 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 13.5 mtt180 -159.95 -146.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -1.113 . . . . 0.0 108.938 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -143.42 157.79 44.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.067 -1.021 . . . . 0.0 109.6 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' C ' ' CD2' ' A' ' 10' ' ' TYR . 3.6 ttpt -112.97 135.7 21.69 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' HG3' ' A' ' 19' ' ' LYS . 34.3 Cg_endo -74.84 143.68 29.94 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.043 1.829 . . . . 0.0 110.526 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -85.21 52.67 2.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.718 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.557 179.832 . . . . . . . . 0 0 . 1 stop_ save_